Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cellular reactive oxygen species (ROS) regulatory machinery is a comprehensive network of enzymes, antioxidants, and transcription factors that maintains redox homeostasis by balancing the production and elimination of reactive species (Sies & Jones, 2020). This system includes primary antioxidant enzymes such as superoxide dismutase (SOD), catalase, and glutathione peroxidase, which neutralize superoxide and hydrogen peroxide to prevent oxidative damage to cellular components (He et al., 2017). A central regulator of this machinery is the transcription factor Nrf2, which induces the expression of numerous antioxidant and detoxification genes in response to oxidative stress (Tonelli et al., 2018). Dysregulation of this machinery is a key driver in the progression of various diseases, including cancer, neurodegeneration, and cardiovascular disorders, where chronic oxidative stress leads to cellular dysfunction (Halliwell & Gutteridge, 2015). Therapeutic strategies often involve modulating this machinery, such as using Nrf2 activators like dimethyl fumarate or ROS scavengers like N-acetylcysteine, to restore balance or enhance cellular protection. However, because ROS also function as vital signaling molecules for cell growth and immune responses, pharmacological interventions must be carefully designed to avoid disrupting essential physiological processes (Sies & Jones, 2020).
The machinery maintains cellular redox balance by enzymatically neutralizing reactive species (e.g., via SOD and Catalase), utilizing small molecule scavengers like glutathione, and activating transcriptional programs (primarily via Nrf2) to upregulate antioxidant defenses in response to oxidative stress.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular reactive oxygen species regulatory machinery (ROS regulatory machinery).